Drug Price Transparency

Name: Drug Price Transparency
Creator: Newspaper Daily
License: United States government work; public domain unless the source record says otherwise.

Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/30/2026
Update schedule: 50 16 1 */3 * UTC
Coverage: 01/01/2024–01/01/2024
Method: Methodology

Record	Record Date	Vuga Group	Change Status	Recency Days	Public Significance Score
Diphtheria-Tetanus Toxoids-Ped	01/01/2024	Tetanus,Diphtheria Toxd Ped/PF	increased	972.23	100
Diphtheria-Tetanus Toxoids-Ped	01/01/2024	Tetanus,Diphtheria Toxd Ped/PF	increased	972.23	100
Doptelet	01/01/2024	Avatrombopag Maleate	increased	972.23	100
Doptelet	01/01/2024	Avatrombopag Maleate	increased	972.23	100
Duaklir Pressair	01/01/2024	Aclidinium Brom/Formoterol Fum	increased	972.23	100
Duaklir Pressair	01/01/2024	Aclidinium Brom/Formoterol Fum	increased	972.23	100
Duaklir Pressair	01/01/2024	Aclidinium Brom/Formoterol Fum	increased	972.23	100
Dupixent Pen	01/01/2024	Dupilumab	increased	972.23	100
Dupixent Pen	01/01/2024	Dupilumab	increased	972.23	100
Dupixent Syringe	01/01/2024	Dupilumab	increased	972.23	100
Dupixent Syringe	01/01/2024	Dupilumab	increased	972.23	100
Durysta	01/01/2024	Bimatoprost	increased	972.23	100
Durysta	01/01/2024	Bimatoprost	increased	972.23	100
Duvyzat	01/01/2024	Givinostat Hydrochloride	increased	972.23	100
Duvyzat	01/01/2024	Givinostat Hydrochloride	increased	972.23	100
Dysport	01/01/2024	Abobotulinumtoxina	increased	972.23	100
Dysport	01/01/2024	Abobotulinumtoxina	increased	972.23	100
Ebglyss Pen	01/01/2024	Lebrikizumab-Lbkz	increased	972.23	100
Ebglyss Pen	01/01/2024	Lebrikizumab-Lbkz	increased	972.23	100
Egrifta Sv	01/01/2024	Tesamorelin Acetate	increased	972.23	100
Egrifta Sv	01/01/2024	Tesamorelin Acetate	increased	972.23	100
Elaprase	01/01/2024	Idursulfase	increased	972.23	100
Elaprase	01/01/2024	Idursulfase	increased	972.23	100
Elelyso	01/01/2024	Taliglucerase Alfa	increased	972.23	100
Elelyso	01/01/2024	Taliglucerase Alfa	increased	972.23	100
Elfabrio	01/01/2024	PEGunigalsidase Alfa-Iwxj	increased	972.23	100
Elfabrio	01/01/2024	PEGunigalsidase Alfa-Iwxj	increased	972.23	100
Eligard	01/01/2024	Leuprolide Acetate	increased	972.23	100
Eligard	01/01/2024	Leuprolide Acetate	increased	972.23	100
Elitek	01/01/2024	Rasburicase	increased	972.23	100
Elitek	01/01/2024	Rasburicase	increased	972.23	100
Elrexfio	01/01/2024	Elranatamab-Bcmm	increased	972.23	100
Elrexfio	01/01/2024	Elranatamab-Bcmm	increased	972.23	100
Emend	01/01/2024	Aprepitant	increased	972.23	100
Emend	01/01/2024	Aprepitant	increased	972.23	100
Emend	01/01/2024	Fosaprepitant Dimeglumine	increased	972.23	100
Emend	01/01/2024	Fosaprepitant Dimeglumine	increased	972.23	100
Emflaza	01/01/2024	Deflazacort	increased	972.23	100
Emflaza	01/01/2024	Deflazacort	increased	972.23	100
Emgality Pen	01/01/2024	Galcanezumab-Gnlm	increased	972.23	100
Emgality Pen	01/01/2024	Galcanezumab-Gnlm	increased	972.23	100
Emgality Syringe	01/01/2024	Galcanezumab-Gnlm	increased	972.23	100
Emgality Syringe	01/01/2024	Galcanezumab-Gnlm	increased	972.23	100
Empaveli	01/01/2024	PEGcetacoplan	increased	972.23	100
Empaveli	01/01/2024	PEGcetacoplan	increased	972.23	100
Empliciti	01/01/2024	Elotuzumab	increased	972.23	100
Empliciti	01/01/2024	Elotuzumab	increased	972.23	100
Emverm	01/01/2024	Mebendazole	increased	972.23	100
Emverm	01/01/2024	Mebendazole	increased	972.23	100
Enbrel Mini	01/01/2024	Etanercept	increased	972.23	100